2024
Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI
Abu-Much A, Grines C, Chen S, Batchelor W, Zhao D, Falah B, Maini A, Redfors B, Bellumkonda L, Bharadwaj A, Moses J, Truesdell A, Zhang Y, Zhou Z, Baron S, Lansky A, Basir M, O'Neill W, Cohen D. Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI. International Journal Of Cardiology 2024, 417: 132555. PMID: 39270940, DOI: 10.1016/j.ijcard.2024.132555.Peer-Reviewed Original ResearchLower left ventricular ejection fractionMitral valve regurgitationPercutaneous coronary interventionHigh-risk PCISevere MRHigh-risk percutaneous coronary interventionMR severityPCI-related complicationsValve regurgitationIII studiesHeart failureAssociated with worse outcomesPrevalence of heart failurePresence of severe MRLower body mass indexVentricular ejection fractionStatistical significanceHigh-risk PCI patientsBody mass indexTrace MREjection fractionModerate MRClinical outcomesMild MRWorse outcomes
2023
TCT-145 Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI: Insights From the cVAD PROTECT III Study
Bonnet G, Rommel K, Falah B, Lansky A, Zhang Y, Schonning M, Redfors B, Burkhoff D, Cohen D, Patel R, Basir B, O’Neill W, Granada J. TCT-145 Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI: Insights From the cVAD PROTECT III Study. Journal Of The American College Of Cardiology 2023, 82: b56-b57. DOI: 10.1016/j.jacc.2023.09.151.Peer-Reviewed Original Research
2018
First‐in‐human experience with Aortix intraaortic pump
Vora A, Jones W, DeVore A, Ebner A, Clifton W, Patel M. First‐in‐human experience with Aortix intraaortic pump. Catheterization And Cardiovascular Interventions 2018, 93: 428-433. PMID: 30311400, PMCID: PMC6586004, DOI: 10.1002/ccd.27857.Peer-Reviewed Original ResearchMeSH KeywordsAgedAortaCoronary Artery DiseaseCoronary CirculationDevice RemovalFeasibility StudiesFemaleGlomerular Filtration RateHeart-Assist DevicesHemodynamicsHumansKidneyKidney DiseasesMaleMiddle AgedParaguayPercutaneous Coronary InterventionProspective StudiesProsthesis DesignProsthesis ImplantationRecovery of FunctionRegional Blood FlowRenal CirculationRisk FactorsTime FactorsTreatment OutcomeUrinationVentricular Dysfunction, LeftVentricular Function, LeftConceptsPercutaneous mechanical circulatory supportHigh-risk PCIRenal dysfunctionVentricular functionAdverse eventsImpaired left ventricular functionFirst-in-human experienceSignificant hemolysisPercutaneous mechanical circulatory support devicesSingle-center studyClinically significant hemolysisLeft ventricular functionPercutaneous coronary intervention patientsHigh-risk percutaneous coronary interventionRenal protective effectsPotential renal protective effectsVascular access complicationsPercutaneous coronary interventionMechanical circulatory supportComplex coronary diseaseVascular closure deviceEstimated GFRUrine outputHemodynamic compromiseSystemic perfusion
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply